Percutaneous permeation modifiers: enhancement versus retardation

Bibliography

• Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004;56(5):581-7
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993;90(22):10504-8
   PubMed Web of Science ®Google Scholar
• Park EJ, Werner J, Smith NB. Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm Res 2007;24(7):1396-401
   PubMed Web of Science ®Google Scholar
• Maibach H, Smith EW. Percutaneous penetration enhancer. Boca Raton: CRC Press; 1995
   Google Scholar
• Walters K. Penetration enhancers and their use in transdermal therapeutic systems. New York: Marcel Dekker, Inc.; 1989
   Google Scholar
• Sinha VR, Kaur MP. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 2000;26(11):1131-40
   PubMed Web of Science ®Google Scholar
• Nedberge D, Campell PS, Gale RM, Yum SI. Transdermal contraceptive formulations. US4816258; 1989
   Google Scholar
• Osdol W, Crisologo NM, Yum SII. Formulations for the transdermal administration of fenoldopam. US6960353; 2005
   Google Scholar
• Baker EL Jr, Warren M, Zack M, et al. Epidemic malathion poisoning in Pakistan malaria workers. Lancet 1978;1(8054):31-4
   PubMed Web of Science ®Google Scholar
• Braue E, Doxzon BF, Lumpkin HL, et al. Military perspectives in chemical penetration retardation. In: Smith E, Maibach HI, editors, Percutaneous penetration enhancers. Boca Raton: CRC, Taylor and Francis; 2006. p. 385-97
   Google Scholar
• Schlumpf M, Jarry H, Wuttke W, et al. Estrogenic activity and estrogen receptor beta binding of the UV filter 3-benzylidene camphor. Comparison with 4-methylbenzylidene camphor. Toxicology 2004;199(2-3):109-20
   PubMed Web of Science ®Google Scholar
• Briassoulis G, Narlioglou M, Hatzis T. Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Hum Exp Toxicol 2001;20(1):8-14
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm 1999;184(1):1-6
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56(5):603-18
   PubMed Web of Science ®Google Scholar
• Kanikkannan N, Singh M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 2002;248(1-2):219-28
   PubMed Web of Science ®Google Scholar
• Moffat V, Green RD, Hadgraft J, et al. Functional siloxanes as skin penetration enhancers. In: Proceedings 18th Controlled Rel Bioact Mat Meeting: 1991; Amsterdam, Netherlands; 1991. p. 536-7
   Google Scholar
• Song Y, Xiao C, Mendelsohn R, et al. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity. Pharm Res 2005;22(11):1918-25
   PubMed Web of Science ®Google Scholar
• Allan G. Azone. In: Maibach H, Smith EW, editors. Percutaneous penetration enhancer. Boca Raton: CRC Press; 1995. p. 129-36
   Google Scholar
• Wester RC, Melendres J, Sedik L, Maibach HI. Percutaneous absorption of azone following single and multiple doses to human volunteers. J Pharm Sci 1994;83(2):124-5
   PubMed Web of Science ®Google Scholar
• Wiechers JW, Drenth BF, Jonkman JH, de Zeeuw RA. Percutaneous absorption and elimination of the penetration enhancer Azone in humans. Pharm Res 1987;4(6):519-23
   PubMed Web of Science ®Google Scholar
• Wiechers JW, Drenth BF, Jonkman JH, de Zeeuw RA. Percutaneous absorption, metabolic profiling, and excretion of the penetration enhancer azone after multiple dosing of an azone-containing triamcinolone acetonide cream in humans. J Pharm Sci 1990;79(2):111-5
   PubMed Web of Science ®Google Scholar
• Barry B. Skin transport. In: Barry B, editor. Dermatological formulations. Volume 18. New York: Marcel Dekker; 1983. p. 95-126
   Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14(2):101-14
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Skin deep. Eur J Pharm Biopharm 2004;58(2):291-9
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Modulation of the barrier function of the skin. Skin Pharmacol Appl Skin Physiol 2001;14(Suppl 1):72-81
   PubMedGoogle Scholar
• Wertz P. The nature of the epidermal barrier: biochemical aspects. Adv Drug Del Rev 1996;18(3):283-94
   Web of Science ®Google Scholar
• Hadgraft J, Guy RH. Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Guy R, Hadgraft J, editors, Transdermal drug delivery. New York: Marcel Dekker; 2003. p. 1-23
   Google Scholar
• Barry BW. Breaching the skin's barrier to drugs. Nat Biotechnol 2004;22(2):165-7
   PubMed Web of Science ®Google Scholar
• Kanikkannan N, Kandimalla K, Lamba SS, Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000;7(6):593-608
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Peck J, Williams DG, et al. Mechanisms of action of skin penetration enhancers/retarders: azone and analogues. Inter J Pharm 1996;141(1-2):17-25
   Web of Science ®Google Scholar
• Hoogstraate AJ, Verhoef J, Brussee J, et al. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int J Pharm 1991;76(1-2):37-47
   Web of Science ®Google Scholar
• Lewis D, Hadgraft J. Mixed monolayers of dipalmitoylphosphatidylcholine with Azone or oleic acid at the air-water interface. Int J Pharm 1990;65(3):211-8
   Web of Science ®Google Scholar
• Brain K, Walters KA. Molecular modeling of skin permeation enhancement by chemical agents. New York: Marcel Dekker; 1993
   Google Scholar
• Hadgraft J, Walters KA. Skin penetration enhancement. In: de Boer A, editor. Drug absorption enhancement, concepts, possibilities, limitations and trends. Volume 177-198. Switzerland: Harwood Academic Publishers; 1994
   Google Scholar
• Kim N, El-Khalili M, Henary MM, et al. Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. Int J Pharm 1999;187(2):219-29
   PubMedGoogle Scholar
• Michniak-Kohn BB. Percutaneous permeation modifiers: enhancement vs retardation. In: AAPS Annual Meeting and Exposition: 2007; San Diego, CA: AAPS; 2007
   Google Scholar
• Kaushik D, Michniak-Kohn BB. Vehicle-enhancer and vehicle-retardant effects on percutaneous permeation of DEET. In: AAPS Annual Meeting and Exposition: 2007; San Diego, CA: AAPS; 2007
   Google Scholar
• Potts RO, Guy, Richard H. Mechanisms of transdermal drug delivery, vol. 83. New York: Marcel Dekker; 1997
   Google Scholar
• Touitou E, Meidan VM, Horwitz E. Methods for quantitative determination of drug localized in the skin. J Control Release 1998;56(1-3):7-21
   PubMed Web of Science ®Google Scholar
• Hammell DC, Stolarczyk EI, Klausner M, et al. Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent. J Pharm Sci 2005;94(4):828-36
   PubMed Web of Science ®Google Scholar
• Valiveti S, Hammell DC, Paudel KS, et al. in vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs. J Control Release 2005;102(2):509-20
   PubMed Web of Science ®Google Scholar
• Coomes MW, Norling AH, Pohl RJ, et al. Foreign compound metabolism by isolated skin cells from the hairless mouse. J Pharmacol Exp Ther 1983;225(3):770-7
   PubMed Web of Science ®Google Scholar
• Milewich L, Kaimal V, Shaw CB. Sontheimer: epidermal keratinocytes: a source of 5 alpha-dihydrotestosterone production in human skin. J Clin Endocrinol Metab 1986;62(4):739-46
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized Sebocyte Cell Line (SEB-1). J Invest Dermatol 2003;120:905-14
   PubMed Web of Science ®Google Scholar
• Cormier M, Ledger PW, Marty JP, Amkraut A. in vitro cutaneous biotransformation of propranolol. J Invest Dermatol 1991;97(3):447-53
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hotchkiss SA, Boobis AR, Edwards RJ. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. Biochem Biophys Res Commun 2002;297(1):65-70
   PubMed Web of Science ®Google Scholar
• Qvist MHHU, Kreilgaard B, Madsen F, et al. Application of confocal laser scanning microsc in characterization of chemical enhancers in drug-in-adhesive transdermal patches. AAPS PharmSci 2002;4(1):1-8
   Google Scholar
• Mendelsohn R, Flach CR, Moore DJ. Determination of molecular conformation and permeation in skin via IR spectroscopy, microscopy, and imaging. Biochim Biophys Acta 2006;1758(7):923-33
   PubMed Web of Science ®Google Scholar
• Plasencia I, Norlen L, Bagatolli LA. Direct visualization of lipid domains in human skin stratum corneum's lipid membranes: effect of pH and temperature. Biophys J 2007;93(9):3142-55
   PubMed Web of Science ®Google Scholar
• Wartewig S, Neubert RH. Pharmaceutical applications of Mid-IR and Raman spectroscopy. Adv Drug Deliv Rev 2005;57(8):1144-70
   PubMed Web of Science ®Google Scholar
• Takahashi K, Sakano H, Yoshida M, et al. Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release 2001;73(2-3):351-8
   PubMed Web of Science ®Google Scholar
• Buyuktimkin S, Buyuktimkin N, Rytting JH. Interaction of indomethacin with a new penetration enhancer, dodecyl 2-(NN-dimethylamino)propionate (DDAIP): its effect on transdermal delivery. Int J Pharm 1996;127(2):245-53
   Web of Science ®Google Scholar
• Pappinen S, Tikkinen S, Pasonen-Seppanen S, et al. Rat epidermal keratinocyte organotypic culture (ROC) compared to human cadaver skin: the effect of skin permeation enhancers. Eur J Pharm Sci 2007;30(3-4):240-50
   PubMed Web of Science ®Google Scholar
• Pelletier M. Analytical applications of Raman spectroscopy. Blackwell Publishing; 1999
   Google Scholar
• Whitehead K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res 2007
   PubMedGoogle Scholar
• Heard CM, Screen C. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane. Int J Pharm 2008;349(1-2):323-5
   PubMedGoogle Scholar
• Andega S, Kanikkannan N, Singh M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release 2001;77(1-2):17-25
   PubMed Web of Science ®Google Scholar
• Babu RJ, Pandit JK. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv 2005;12(3):165-9
   PubMed Web of Science ®Google Scholar
• Sarigullu Ozguney I, Yesim Karasulu H, Kantarci G, et al. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech 2006;7(4):88
   PubMedGoogle Scholar
• Kandimalla K, Kanikkannan N, Andega S, Singh M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in vitro and on the transepidermal water loss in rats in vivo. J Pharm Pharmacol 1999;51(7):783-90
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Shokri J, Dashbolaghi A, et al. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003;250(2):359-69
   PubMed Web of Science ®Google Scholar
• Sarpotdar PP, Zatz JL. Percutaneous absorption enhancement by non-ionic surfactants. Drug Dev Ind Pharm 1986;12:1625-47
   Web of Science ®Google Scholar
• Godwin DA, Michniak BB. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm 1999;25(8):905-15
   PubMed Web of Science ®Google Scholar
• Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today 2007;12(23-24):1061-7
   PubMed Web of Science ®Google Scholar
• Valenta C, Dabic T. Effect of urea and pantothenol on the permeation of progesterone through excised rat skin from polymer matrix systems. Drug Dev Ind Pharm 2001;27(1):57-62
   PubMed Web of Science ®Google Scholar
• Fincher TK, Yoo SD, Player MR, et al. in vitro evaluation of a series of N-dodecanoyl-L-amino acid methyl esters as dermal penetration enhancers. J Pharm Sci 1996;85(9):920-3
   PubMed Web of Science ®Google Scholar
• Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 2005;298(1):98-107
   PubMed Web of Science ®Google Scholar
• Godwin DA, Michniak BB, Player MR, Sowell JW Sr. Transdermal and dermal enhancing activity of pyrrolidinones in hairless mouse skin. Int J Pharm 1997;155:241-50
   Google Scholar
• Buyuktimkin S, Buyuktimkin N, Rytting JH. Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone. Pharm Res 1993;10(11):1632-7
   PubMed Web of Science ®Google Scholar